Yin Z, Kang J, Xu H, Huo S, Xu H
Cell Regen. 2024; 13(1):30.
PMID: 39663301
PMC: 11635068.
DOI: 10.1186/s13619-024-00211-z.
Yin Z, Kang J, Cheng X, Gao H, Huo S, Xu H
Neural Regen Res. 2024; 20(4):946-959.
PMID: 38989930
PMC: 11438324.
DOI: 10.4103/NRR.NRR-D-23-01612.
Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R
Brain Sci. 2023; 13(3).
PMID: 36979334
PMC: 10046178.
DOI: 10.3390/brainsci13030524.
El-Mezayen N, Attia M, Shafik M, Gowied H, Abdel-Aal H, Abdel-Hady S
CNS Neurosci Ther. 2023; 29(8):2111-2128.
PMID: 36949616
PMC: 10352881.
DOI: 10.1111/cns.14179.
Liu S, Xiang K, Yuan F, Xiang M
iScience. 2023; 26(3):106241.
PMID: 36922996
PMC: 10009094.
DOI: 10.1016/j.isci.2023.106241.
Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART.
Ehrenberg A, Kelberman M, Liu K, Dahl M, Weinshenker D, Falgas N
Alzheimers Dement. 2023; 19(5):2182-2196.
PMID: 36642985
PMC: 10182252.
DOI: 10.1002/alz.12937.
Application and prospects of somatic cell reprogramming technology for spinal cord injury treatment.
Yang R, Pan J, Wang Y, Xia P, Tai M, Jiang Z
Front Cell Neurosci. 2022; 16:1005399.
PMID: 36467604
PMC: 9712200.
DOI: 10.3389/fncel.2022.1005399.
NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury.
Tan Z, Qin S, Yuan Y, Hu X, Huang X, Liu H
Theranostics. 2022; 12(10):4548-4563.
PMID: 35832093
PMC: 9254256.
DOI: 10.7150/thno.71378.
MicroRNA Roles in Cell Reprogramming Mechanisms.
Pascale E, Caiazza C, Paladino M, Parisi S, Passaro F, Caiazzo M
Cells. 2022; 11(6).
PMID: 35326391
PMC: 8946776.
DOI: 10.3390/cells11060940.
Neural Stem Cell-Derived Exosomal Netrin1 Contributes to Neuron Differentiation of Mesenchymal Stem Cells in Therapy of Spinal Bifida Aperta.
Ma L, Wei X, Ma W, Liu Y, Wang Y, He Y
Stem Cells Transl Med. 2022; 11(5):539-551.
PMID: 35325230
PMC: 9154334.
DOI: 10.1093/stcltm/szac009.
Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons.
Han F, Liu Y, Huang J, Zhang X, Wei C
Front Aging Neurosci. 2021; 13:738529.
PMID: 34658841
PMC: 8515543.
DOI: 10.3389/fnagi.2021.738529.
Generation of Induced Dopaminergic Neurons from Human Fetal Fibroblasts.
Legault E, Drouin-Ouellet J
Methods Mol Biol. 2021; 2352:97-115.
PMID: 34324182
DOI: 10.1007/978-1-0716-1601-7_7.
Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application.
Vasan L, Park E, David L, Fleming T, Schuurmans C
Front Cell Dev Biol. 2021; 9:681087.
PMID: 34291049
PMC: 8287587.
DOI: 10.3389/fcell.2021.681087.
Reprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise.
Wang F, Cheng L, Zhang X
Neurosci Bull. 2021; 37(11):1625-1636.
PMID: 34283396
PMC: 8566647.
DOI: 10.1007/s12264-021-00751-3.
Making Sense of Patient-Derived iPSCs, Transdifferentiated Neurons, Olfactory Neuronal Cells, and Cerebral Organoids as Models for Psychiatric Disorders.
Unterholzner J, Millischer V, Wotawa C, Sawa A, Lanzenberger R
Int J Neuropsychopharmacol. 2021; 24(10):759-775.
PMID: 34216465
PMC: 8538891.
DOI: 10.1093/ijnp/pyab037.
Reprogramming astrocytes to motor neurons by activation of endogenous Ngn2 and Isl1.
Zhou M, Tao X, Sui M, Cui M, Liu D, Wang B
Stem Cell Reports. 2021; 16(7):1777-1791.
PMID: 34171285
PMC: 8282467.
DOI: 10.1016/j.stemcr.2021.05.020.
Induced Neurons for Disease Modeling and Repair: A Focus on Non-fibroblastic Cell Sources in Direct Reprogramming.
Kim K, Thaqi M, Peterson D, Marr R
Front Bioeng Biotechnol. 2021; 9:658498.
PMID: 33777923
PMC: 7995206.
DOI: 10.3389/fbioe.2021.658498.
Molecular Mechanisms Underlying Ascl1-Mediated Astrocyte-to-Neuron Conversion.
Rao Z, Wang R, Li S, Shi Y, Mo L, Han S
Stem Cell Reports. 2021; 16(3):534-547.
PMID: 33577795
PMC: 7940254.
DOI: 10.1016/j.stemcr.2021.01.006.
How to reprogram human fibroblasts to neurons.
Xu Z, Su S, Zhou S, Yang W, Deng X, Sun Y
Cell Biosci. 2020; 10:116.
PMID: 33062254
PMC: 7549215.
DOI: 10.1186/s13578-020-00476-2.
Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons.
Nolbrant S, Giacomoni J, Hoban D, Bruzelius A, Birtele M, Chandler-Militello D
Stem Cell Reports. 2020; 15(4):869-882.
PMID: 32976765
PMC: 7562948.
DOI: 10.1016/j.stemcr.2020.08.013.